Wall Street goes BULLISH now

Join TradeAlgo's Free Live Trading Session ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ [EARN WHILE YOU LEARN! JOIN OUR FREE LIVE TRADING SESSION!]( Hello investor, Wall Street goes BULLISH now Things are bullish on Wall Street again. The Dow Jones notched its longest win streak since December. Stocks are still rallying after the weak jobs data made it likely for a rate cut to happen this year. The strong earnings season also boosted the strength of the market. Moreover, yesterday’s jobless claims came in higher than expected. Meaning? More people are unemployed. This indicated a weakening labor market which could give the central bank a green light to cut interest rates soon. Chris Hyzy at Merrill and Bank of America Private Bank believed that we just witnessed of early stages of a long-term bull market. - “What’s important in all of this context is, ‘are we in the early stages of a long-term bull market or not?’” Chris Hyzy, chief investment officer of Merrill and Bank of America Private Bank. - “It feels comfortable saying it on a day like this, but we are, in our opinion.” Chris Hyzy, chief investment officer of Merrill and Bank of America Private Bank (Photo: CNBC) A bunch of Federal Reserve officials will speak today — Fed presidents Lorie Logan of Dallas, Neel Kashkari of Minneapolis and Austan Goolsbee of Chicago, along with Fed Governor Michelle Bowman. Don’t expect their comments to move the markets much, though. As long as the economy continues to weaken modestly (but not too much), it should give stocks a room to rally. Inflation, of course, has to cool down. A terrible scenario would be if the economy slows down rapidly while inflation remains high. It will make it difficult for the Federal Reserve to cut rates immediately. Stay posted. The Unique REIT Stock Holds A Special Competitive Moat In The Niche Of Life Science Today’s Stock Pick: Alexandria Real Estate ([ARE]( Alexandria isn’t your average REIT stock. It is an enlightened company with a mission to change the world. It also understands the power of niche to create an unmatched competitive advantage. Alexandria is a real estate property company that focuses exclusively on life science. It doesn’t view itself as a real estate company. Rather, it is a community that drives innovation in the space. The heart of Alexandria’s business model is the theory of cluster, pioneered by Harvard Business Professor Michael E. Porter. For a life science company to succeed, it needs to be in the right “cluster.” There are four critical components for the cluster theory — location, innovation, talent, and capital. Basically, you need to be in the location that is brewing with talent. Information flows faster. The talent pipeline is robust from elite universities. And there are capitalists in the area to fund the growth. Precisely, Alexandria’s vision is to create a cluster mega-campus strategy. Alexandria’s buildings are amenity-rich. They are thoughtfully designed to deliver a highly-complex infrastructure for life sciences. That’s the beauty of Alexandria. The complexity of life sciences makes it difficult for competitors to enter Alexandria’s market. In fact, co-founder Joel Marcus is credited for turning Cambridge, Mass. into one of the world’s biggest biotech hubs. Joel started as a lawyer representing firms that wanted laboratory space near major academic institutions. That was his insight – he foresaw the demand for customized commercial buildings designed for labs that are built close to talent hubs in universities. Eventually, he was approached to start a real estate company for biotech companies. The rest was history. Here’s an astonishing statistic to understand the dominance of Alexandria in life science. One hundred percent of FDA-approved engineered gene and cell therapies were developed or owned by tenants of Alexandria. Can you believe it?! So, what is the result of Alexandria’s enlightened mission? Extraordinary growth. Its net income grew by 299% since 2014. And remember, this doesn’t include annual dividends since Alexandria’s a REIT stock. All in all, you’d get phenomenal net income growth along with high dividends. (Source: Alexandria Real Estate) Since Alexandria’s IPO in May 1997, the stock’s total shareholder return exceeded 1,512% from IPO through Dec. 31, 2023. And remember that its return counted through two major stock market crashes – the dot-com crash, the 2007-09 housing crisis, and the pandemic crash. (Source: Alexandria Real Estate) The largest acquisition ever: Last year, Alexandria completed its largest acquisition in company history -- a $1.48 billion foundational life science campus aggregating nearly 2 million RSF, in Fenway, Boston. The company understands the power of branding, and it named the building the Alexandria Center® for Life Science – Fenway. A venture capital arm: Alexandria isn’t just a REIT company, though. It formed a venture capital arm, where it invested in trailblazing life science companies that will positively impact human health. And it has tentacles in agrifoodtech, as well. These investments keep Alexandria close to the new trends of science and technology and curate the highest-quality tenant base. Alexandria Venture Investments was recognized as the most active corporate investor in biopharma by new deal volume and as one of the top five most active U.S.-based investors in agrifoodtech for several years. Bottom line: Alexandria is a unicorn in the REIT sector, where it has a powerful brand in building mega campuses for groundbreaking companies. In fact, Moderna’s HQ is owned by Alexandria along with Moderna’s other three campuses. Its dividend yield is 4.2%, and with its robust pipeline of new value-creation projects, the earnings are sure to grow for many years to come. Owning Alexandria is like owning Apple of REIT with its powerful brand operating in a hot sector of biotech. This is one-of-a-kind stock, and you’d never sell it once you own it. [EARN WHILE YOU LEARN! JOIN OUR FREE LIVE TRADING SESSION!](       © All Rights Reserved, Trade Alliance [Unsubscribe]( | [Manage Preferences](